Conducting cutting edge research at Oxford (photo: John Cairns)
Oxford Research Centre, Innovation Building, Old Road Campus, University of Oxford
In silico drug target identification at NNRCO (photo: John Cairns)
Our Research Centre Oxford currently has four research teams onsite, working together to solve complex scientific challenges using human genetics, big data and cutting-edge technologies. The Oxford site drives in house discovery efforts with external collaborators, in partnership with other Novo Nordisk international sites. The global collaboration contributes to our overall pipeline and to greater scientific understanding to help solve unmet needs in the diabetes and cardiometabolic fields.
With Novo Nordisk Research Centre Oxford’s strategic location in the golden triangle academic centers of excellence (Oxford, London and Cambridge), the site embraces academic-industrial collaboration opportunities in this unique and innovative ecosystem. Our relationship with the University of Oxford started more than 20 years ago, with Novo Nordisk being one of the founding partners for the Oxford Centre for Diabetes, Endocrinology and Metabolism. The current fellowship programme with the University of Oxford was established in 2013. Our strategic alliance with the University of Oxford, as well as the establishment of our Research Centre Oxford, was announced in January 2017. The joint ambition for the research centre is to combine our experience in developing treatments for diabetes with the expertise of renowned scientists from the University of Oxford.
Dr. Bill Haynes has been the site head of Novo Nordisk Research Centre Oxford since December 2018. Bill is a physician-scientist with more than 20 years of experience in academic-industry translational research across cardio-metabolic diseases.
Novo Nordisk Research Centre Oxford